MBHB Partner Andrew Williams Quoted in LSIPR Article Entitled, “Ranbaxy receives notice for acne drug generic”

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Andrew Williams is quoted in a September 24, 2013 online edition of Life Sciences Intellectual Property Review in an article entitled, “Ranbaxy receives notice for acne drug generic.” Drug company Watson Laboratories (Actavis) has notified rival Ranbaxy Laboratories that it has applied to sell a generic version of anti-acne product Absorica in the US. View the article